A detailed history of Vaughan Nelson Investment Management, L.P. transactions in Danaher Corp stock. As of the latest transaction made, Vaughan Nelson Investment Management, L.P. holds 909,707 shares of DHR stock, worth $219 Million. This represents 1.99% of its overall portfolio holdings.

Number of Shares
909,707
Previous 608,195 49.57%
Holding current value
$219 Million
Previous $141 Million 61.46%
% of portfolio
1.99%
Previous 1.4%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

BUY
$224.58 - $256.19 $67.7 Million - $77.2 Million
301,512 Added 49.57%
909,707 $227 Million
Q4 2023

Jan 24, 2024

BUY
$185.1 - $233.13 $1.6 Million - $2.02 Million
8,668 Added 1.45%
608,195 $141 Million
Q3 2023

Nov 09, 2023

BUY
$233.08 - $265.59 $41.5 Million - $47.2 Million
177,905 Added 42.2%
599,527 $149 Million
Q2 2023

Aug 03, 2023

SELL
$224.99 - $256.14 $78 Million - $88.8 Million
-346,722 Reduced 45.13%
421,622 $101 Million
Q1 2023

May 05, 2023

BUY
$239.75 - $277.0 $5.71 Million - $6.59 Million
23,807 Added 3.2%
768,344 $194 Million
Q4 2022

Jan 30, 2023

BUY
$241.42 - $282.29 $11.6 Million - $13.5 Million
47,865 Added 6.87%
744,537 $198 Million
Q3 2022

Nov 04, 2022

BUY
$247.06 - $1507.4 $49.7 Million - $303 Million
201,056 Added 40.57%
696,672 $180 Million
Q2 2022

Jul 22, 2022

SELL
$237.11 - $299.66 $71.7 Million - $90.6 Million
-302,475 Reduced 37.9%
495,616 $126 Million
Q1 2022

May 04, 2022

SELL
$257.27 - $315.76 $5.82 Million - $7.15 Million
-22,635 Reduced 2.76%
798,091 $234 Million
Q4 2021

Jan 13, 2022

BUY
$292.08 - $329.01 $33.7 Million - $37.9 Million
115,221 Added 16.33%
820,726 $270 Million
Q3 2021

Oct 27, 2021

BUY
$272.21 - $332.43 $192 Million - $235 Million
705,505 New
705,505 $215 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $175B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Vaughan Nelson Investment Management, L.P. Portfolio

Follow Vaughan Nelson Investment Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vaughan Nelson Investment Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Vaughan Nelson Investment Management, L.P. with notifications on news.